Cargando…
High prevalence of asymptomatic SARS-CoV-2 infection in a cohort of liver transplant recipients in central Italy
Asymptomatic subjects account for 25 to 45% of SARS-CoV-2 infections, and in particular, subjects on mild immunosuppressive therapy may have symptoms masked and could spread virus for an extended period of time. To determine the cumulative incidence of symptomatic and asymptomatic SARS-CoV-2 infecti...
Autores principales: | Visco-Comandini, Ubaldo, Castilletti, Concetta, Lionetti, Raffaella, Meschi, Silvia, Montalbano, Marzia, Rianda, Alessia, Taibi, Chiara, Sorace, Chiara, Guglielmo, Nicola, Piccolo, Paola, Paci, Paola, Ettorre, Giuseppe Maria, Gianpiero, D'Offizi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684051/ http://dx.doi.org/10.1016/j.liver.2021.100064 |
Ejemplares similares
-
Does m-RNA vaccination protect from Sars-Cov2 (asymptomatic) infection in liver transplant recipients?
por: Comandini, Ubaldo Visco, et al.
Publicado: (2022) -
Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors
por: Garbuglia, Anna Rosa, et al.
Publicado: (2016) -
Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study
por: Biliotti, Elisa, et al.
Publicado: (2023) -
Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents
por: Bartolini, Barbara, et al.
Publicado: (2017) -
The impact of the coronavirus disease 2019 pandemic on a central Italy transplant center
por: Montalbano, Marzia, et al.
Publicado: (2020)